This announcement is a separate document:
中信证券股份有限公司关于上海凯赛生物技术股份有限公司差异化分红事项的核查意见
CITIC Securities Co., Ltd.'s verification opinion on the differential dividend issue of Shanghai Cathay Biotechnology Inc.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.